Department of Anesthesia, Cardiac Anesthesia Division, Maastricht University Medical Center, Maastricht, the Netherlands.
J Cardiothorac Vasc Anesth. 2012 Jun;26(3):448-54. doi: 10.1053/j.jvca.2012.01.034. Epub 2012 Mar 28.
A variety of lung-protective techniques, including continuous positive airway pressure and vital capacity maneuvers, have been suggested as beneficial when applied during cardiopulmonary bypass (CPB). To better define the efficacy of these techniques, a systematic review of different ventilation strategies during and after CPB was performed.
A systematic review and meta-analysis according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses recommendations.
Hospitals.
Eight hundred fourteen participants of 16 randomized controlled trials.
Continuous positive airway pressure (CPAP), low-volume ventilation, or vital capacity maneuvers (VCMs) during CPB.
The methodologic validity of the included trials was scored according to the Oxford scale. Included trials had to report on at least 1 of the following parameters: oxygenation, oxygenation index, alveolar-arterial oxygen difference, or shunt fraction. The average quality of the included trials was as low as 2 on a scale from 1 to 5. The use of CPAP or VCM during CPB led to a significant increase in oxygenation parameters immediately after weaning from CPB, but this effect was not sustainable and did not improve patient outcome.
This meta-analysis showed that the positive effects of the designated techniques are probably short-lived with a questionable impact on the long-term clinical outcome of the treated patients. Based on the available data, it might be impossible to advise an optimal or best-evidence strategy of lung preservation during CPB.
各种肺保护技术,包括持续气道正压通气和肺活量操作,已被建议在体外循环(CPB)期间应用有益。为了更好地定义这些技术的疗效,对 CPB 期间和之后的不同通气策略进行了系统评价和荟萃分析。
根据系统评价和荟萃分析的首选报告项目建议进行系统评价和荟萃分析。
医院。
16 项随机对照试验的 814 名参与者。
CPB 期间的持续气道正压通气(CPAP)、低容量通气或肺活量操作(VCM)。
根据牛津量表对纳入试验的方法学有效性进行评分。纳入的试验必须报告以下至少一个参数:氧合、氧合指数、肺泡-动脉氧差或分流分数。纳入试验的平均质量低至 2 分(满分 5 分)。CPB 期间使用 CPAP 或 VCM 可显著增加 CPB 脱机后即刻的氧合参数,但这种效果是短暂的,不能改善患者的预后。
本荟萃分析表明,指定技术的积极影响可能是短暂的,对治疗患者的长期临床结局的影响值得怀疑。根据现有数据,可能不可能为 CPB 期间的肺保护提供最佳或最佳证据策略。